We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...

Bearish flow noted in Teva (TEVA) with 3,687 puts trading, or 4x expected. Most active are Dec-24 17 puts and Jan-25 17 calls, with total ...

UBS walked away from meetings with Teva (TEVA) management confident that the firm’s bullish thesis with a Street-high price target of $26 ...

In terms of liquidity and interest, the mean open interest for Teva Pharmaceutical Indus options trades today is 8263.67 with ...

European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA0.70%increase; green up pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...

Teva Hit With €463 Million EU Fine for Talking Down Rivals EU says Israeli firm thwarted competition for MS drug Teva vows to appeal decision, says it is ‘deeply dissapointed’ ...

TVB-009P, Teva’s proposed biosimilar to Prolia, is the first of Teva’s internally developed biosimilars to be submitted to the U.S. FDA. The submissions are supported by a comprehensive ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...